Boston Scientific Free Cash Flow 2010-2024 | BSX
- Boston Scientific free cash flow for the quarter ending June 30, 2024 was 644.00, a year-over-year.
- Boston Scientific free cash flow for the twelve months ending June 30, 2024 was , a year-over-year.
- Boston Scientific annual free cash flow for 2023 was $1.796B, a 89.05% increase from 2022.
- Boston Scientific annual free cash flow for 2022 was $0.95B, a 28.57% decline from 2021.
- Boston Scientific annual free cash flow for 2021 was $1.33B, a 16.26% increase from 2020.
Boston Scientific Annual Free Cash Flow | |
---|---|
2023 | 1,796.00 |
2022 | 950.00 |
2021 | 1,330.00 |
2020 | 1,144.00 |
2019 | 1,382.00 |
2018 | 8.00 |
2017 | 1,107.00 |
2016 | 835.00 |
2015 | 444.00 |
2014 | 1,010.00 |
2013 | 918.00 |
2012 | 1,070.00 |
2011 | 720.00 |
2010 | 58.00 |
2009 | 528.00 |
Boston Scientific Quarterly Free Cash Flow | |
---|---|
2024-06-30 | 644.00 |
2024-03-31 | -14.00 |
2023-12-31 | 1,796.00 |
2023-09-30 | 1,106.00 |
2023-06-30 | 597.00 |
2023-03-31 | 82.00 |
2022-12-31 | 950.00 |
2022-09-30 | 353.00 |
2022-06-30 | 32.00 |
2022-03-31 | -171.00 |
2021-12-31 | 1,330.00 |
2021-09-30 | 1,114.00 |
2021-06-30 | 753.00 |
2021-03-31 | 213.00 |
2020-12-31 | 1,144.00 |
2020-09-30 | 624.00 |
2020-06-30 | 28.00 |
2020-03-31 | -174.00 |
2019-12-31 | 1,382.00 |
2019-09-30 | 874.00 |
2019-06-30 | 490.00 |
2019-03-31 | 289.00 |
2018-12-31 | 8.00 |
2018-09-30 | 81.00 |
2018-06-30 | -344.00 |
2018-03-31 | 133.00 |
2017-12-31 | 1,107.00 |
2017-09-30 | 502.00 |
2017-06-30 | 110.00 |
2017-03-31 | -119.00 |
2016-12-31 | 835.00 |
2016-09-30 | 326.00 |
2016-06-30 | 428.00 |
2016-03-31 | 86.00 |
2015-12-31 | 444.00 |
2015-09-30 | 109.00 |
2015-06-30 | -229.00 |
2015-03-31 | -243.00 |
2014-12-31 | 1,010.00 |
2014-09-30 | 649.00 |
2014-06-30 | 359.00 |
2014-03-31 | 139.00 |
2013-12-31 | 918.00 |
2013-09-30 | 727.00 |
2013-06-30 | 533.00 |
2013-03-31 | 187.00 |
2012-12-31 | 1,070.00 |
2012-09-30 | 727.00 |
2012-06-30 | 501.00 |
2012-03-31 | 146.00 |
2011-12-31 | 720.00 |
2011-09-30 | 438.00 |
2011-06-30 | 141.00 |
2011-03-31 | -166.00 |
2010-12-31 | 58.00 |
2010-09-30 | -333.00 |
2010-06-30 | -129.00 |
2010-03-31 | -354.00 |
2009-12-31 | 528.00 |
2009-09-30 | 939.00 |
2009-06-30 | 546.00 |
2009-03-31 | 201.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $123.450B | $14.240B |
Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $203.272B | 26.25 |
Stryker (SYK) | United States | $140.156B | 32.75 |
Medtronic (MDT) | Ireland | $115.424B | 17.18 |
EssilorLuxottica (ESLOY) | France | $105.988B | 0.00 |
Haleon (HLN) | United Kingdom | $47.352B | 34.60 |
Lonza Group Ag (LZAGY) | Switzerland | $46.218B | 0.00 |
ResMed (RMD) | United States | $36.837B | 32.43 |
Koninklijke Philips (PHG) | Netherlands | $28.913B | 21.97 |
Terumo (TRUMY) | Japan | $27.831B | 39.31 |
Zimmer Biomet Holdings (ZBH) | United States | $21.412B | 13.48 |
Baxter (BAX) | United States | $20.091B | 13.63 |
Insulet (PODD) | United States | $16.158B | 67.98 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.705B | 0.00 |
Demant (WILYY) | Denmark | $9.197B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.972B | 29.73 |
BellRing Brands (BRBR) | United States | $7.584B | 32.07 |
Lantheus Holdings (LNTH) | United States | $7.223B | 17.34 |
ICU Medical (ICUI) | United States | $4.254B | 40.60 |
Haemonetics (HAE) | United States | $3.749B | 18.55 |
Perrigo (PRGO) | Ireland | $3.702B | 11.70 |
Prestige Consumer Healthcare (PBH) | United States | $3.613B | 18.00 |
TG Therapeutics (TGTX) | United States | $3.590B | 38.02 |
GN Store Nord (GNNDY) | Denmark | $3.560B | 21.44 |
Neogen (NEOG) | United States | $3.357B | 35.23 |
Envista Holdings (NVST) | United States | $3.210B | 17.13 |
QuidelOrtho (QDEL) | United States | $3.012B | 18.98 |
Agios Pharmaceuticals (AGIO) | United States | $2.556B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.190B | 36.75 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.172B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.981B | 52.80 |
AdaptHealth (AHCO) | United States | $1.451B | 10.48 |
Warby Parker (WRBY) | United States | $1.445B | 0.00 |
InMode (INMD) | Israel | $1.407B | 8.96 |
AtriCure (ATRC) | United States | $1.349B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.124B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.120B | 0.00 |
Owens & Minor (OMI) | United States | $1.109B | 8.57 |
Evolus (EOLS) | United States | $1.039B | 0.00 |
PetIQ (PETQ) | United States | $0.916B | 23.23 |
Phibro Animal Health (PAHC) | United States | $0.859B | 17.82 |
National Vision Holdings (EYE) | United States | $0.816B | 25.95 |
Cresco Labs (CRLBF) | United States | $0.810B | 0.00 |
Surmodics (SRDX) | United States | $0.557B | 118.21 |
Valneva SE (VALN) | France | $0.486B | 0.00 |
Quanterix (QTRX) | United States | $0.479B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.470B | 14.17 |
ZimVie (ZIMV) | United States | $0.448B | 41.64 |
Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
Jin Medical (ZJYL) | China | $0.394B | 0.00 |
Cerus (CERS) | United States | $0.378B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.341B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.318B | 8.19 |
Biote (BTMD) | United States | $0.311B | 14.32 |
Aurora Cannabis (ACB) | Canada | $0.309B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.303B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.290B | 31.12 |
Zynex (ZYXI) | United States | $0.250B | 43.83 |
Ayr Wellness (AYRWF) | United States | $0.233B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.229B | 15.22 |
MacroGenics (MGNX) | United States | $0.226B | 0.00 |
Omeros (OMER) | United States | $0.217B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.191B | 0.00 |
High Tide (HITI) | Canada | $0.177B | 0.00 |
FitLife Brands (FTLF) | United States | $0.155B | 20.87 |
TriSalus Life Sciences (TLSI) | United States | $0.151B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.136B | 0.00 |
Brainsway (BWAY) | Israel | $0.134B | 161.00 |
Rockwell Medical (RMTI) | United States | $0.129B | 0.00 |
Veru (VERU) | United States | $0.122B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.120B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.107B | 0.00 |
Fonar (FONR) | United States | $0.105B | 10.61 |
Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 23.60 |
InterCure (INCR) | Israel | $0.090B | 15.15 |
Cellectar Biosciences (CLRB) | United States | $0.076B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.073B | 0.00 |
Safety Shot (SHOT) | United States | $0.072B | 0.00 |
Modular Medical (MODD) | United States | $0.071B | 0.00 |
MariMed (MRMD) | United States | $0.065B | 0.00 |
Cytosorbents (CTSO) | United States | $0.058B | 0.00 |
Exagen (XGN) | United States | $0.052B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.050B | 3.25 |
Apyx Medical (APYX) | United States | $0.043B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
Bright Green (BGXX) | United States | $0.039B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
Nephros (NEPH) | United States | $0.020B | 0.00 |
GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
Flora Growth (FLGC) | United States | $0.012B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
Sharps Technology (STSS) | United States | $0.007B | 0.00 |
Agape ATP (ATPC) | $0.006B | 0.00 | |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.002B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 20.07 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |